Smart Nanoparticles Deliver mRNA to Tumors, Reprogramming Immune Cells

Researchers have developed a new cancer therapy that uses engineered nanoparticles to deliver mRNA directly to tumors. The treatment targets immune cells that have been corrupted or suppressed by cancer, effectively reprogramming them. By restoring these immune cells, the therapy strengthens the body's natural ability to identify and attack cancer. This approach represents a potential advance in using mRNA technology beyond vaccines, applying it as a targeted cancer treatment.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.




Discussion (0)
Log in to join the discussion and vote.
Log in